These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 36675027)

  • 1. Rejuvenating the Activity of Usual Antibiotics on Resistant Gram-Negative Bacteria: Recent Issues and Perspectives.
    Tabcheh J; Vergalli J; Davin-Régli A; Ghanem N; Pages JM; Al-Bayssari C; Brunel JM
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
    Liu Y; Li R; Xiao X; Wang Z
    Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-Resistant Gram-Negative Bacteria and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae from the Poultry Farm Environment.
    Veloo Y; Thahir SSA; Rajendiran S; Hock LK; Ahmad N; Muthu V; Shaharudin R
    Microbiol Spectr; 2022 Jun; 10(3):e0269421. PubMed ID: 35467407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Peptidomimetics Prevent the Development of Resistance against Gentamicin and Ciprofloxacin in Staphylococcus and Pseudomonas Bacteria.
    Browne K; Kuppusamy R; Walsh WR; Black DS; Willcox MDP; Kumar N; Chen R
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids.
    Gupta V; Datta P
    Indian J Med Res; 2019 Feb; 149(2):97-106. PubMed ID: 31219074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics resistance as a major public health concern: A pharmaco-epidemiological study to evaluate prevalence and antibiotics susceptibility-resistance pattern of bacterial isolates from multiple teaching hospitals.
    Bashir N; Dablool AS; Khan MI; Almalki MG; Ahmed A; Mir MA; Hamdoon AAE; Elawad MA; Mosa OF; Niyazov LN; Elkhalifa MEM; Alghamdi MA; Anwar A; Ayaz M
    J Infect Public Health; 2023 Dec; 16 Suppl 1():61-68. PubMed ID: 37880004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for infections caused by multidrug-resistant Gram-negative bacteria: a guide to good clinical practice.
    Delroba K; Alaei M; Khalili H
    Future Microbiol; 2023 Mar; 18():287-294. PubMed ID: 37140271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic adjuvants against multidrug-resistant Gram-negative bacteria: important component of future antimicrobial therapy.
    Li W; Tao Z; Zhou M; Jiang H; Wang L; Ji B; Zhao Y
    Microbiol Res; 2024 Oct; 287():127842. PubMed ID: 39032266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Assessment of Antimicrobial Resistance in Gram-Negative and Gram-Positive Infective Endocarditis: A Multicentric Retrospective Analysis.
    Budea CM; Pricop M; Mot IC; Horhat FG; Hemaswini K; Akshay R; Negrean RA; Oprisoni AL; Citu C; Bumbu BA; Adi A; Khan I; Mavrea A; Bogdan I; Bota AV; Fericean RM; Marincu I
    Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984458
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention.
    Tzialla C; Borghesi A; Pozzi M; Stronati M
    Clin Chim Acta; 2015 Dec; 451(Pt A):71-7. PubMed ID: 25749408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics.
    Huang Z; Zhang X; Yao Z; Han Y; Ye J; Zhang Y; Chen L; Shen M; Zhou T
    mSphere; 2023 Jun; 8(3):e0054922. PubMed ID: 37017551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Original and Efficient Antibiotic Adjuvant Strategy to Enhance the Activity of Macrolide Antibiotics against Gram-Negative Resistant Strains.
    Troudi A; Bolla JM; Klibi N; Brunel JM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
    Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
    Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motuporamine Derivatives as Antimicrobial Agents and Antibiotic Enhancers against Resistant Gram-Negative Bacteria.
    Borselli D; Blanchet M; Bolla JM; Muth A; Skruber K; Phanstiel O; Brunel JM
    Chembiochem; 2017 Feb; 18(3):276-283. PubMed ID: 28098416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combination of Antibiotic and Non-Antibiotic Compounds Improves Antibiotic Efficacy against Multidrug-Resistant Bacteria.
    Xiao G; Li J; Sun Z
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
    Conway SP; Brownlee KG; Denton M; Peckham DG
    Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.